VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
SIGASIGA Technologies, Inc.
$4.32$310M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

SIGA logoSIGA Technologies, Inc.(SIGA)Earnings, Financials & Key Ratios

SIGA•NASDAQ
13.1× P/E·Price updated Jun 19, 2026
SectorHealthcareIndustrySpecialty & Generic PharmaSub-IndustryVaccines and biodefense products
AboutSIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.Show more
  • Revenue$95M-31.8%
  • EBITDA$24M-65.6%
  • Net Income$23M-60.7%
  • EPS (Diluted)0.33-60.2%
  • Gross Margin68.57%-11.5%
  • EBITDA Margin25.65%-49.6%
  • Operating Margin25.05%-50.3%
  • Net Margin24.63%-42.3%
  • ROE11.24%-60.8%

SIGA Key Insights

SIGA Technologies, Inc. (SIGA) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Company is almost debt free
  • ✓Excellent 3Y average ROE of 25.7%
  • ✓FCF machine: 45.6% free cash flow margin
  • ✓High quality earnings: Operating CF exceeds net income
  • ✓Healthy 5Y average net margin of 39.7%

✗Weaknesses

  • ✗Profits declining 16.2% over 5 years
  • ✗Weak momentum: RS Rating 17 (bottom 17%)
  • ✗Sales declining 5.4% over 5 years
  • ✗Dividend payout exceeds 100% of earnings
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when SIGA posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

SIGA Price & Volume

SIGA Technologies, Inc. (SIGA) stock price & volume — 10-year historical chart

Loading chart...

SIGA Growth Metrics

SIGA Technologies, Inc. (SIGA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years27.74%
5 Years-5.41%
3 Years-5.13%
TTM-22.06%

Profit CAGR

10 Years-
5 Years-16.19%
3 Years-11.75%
TTM-58.25%

EPS CAGR

10 Years-
5 Years-14.21%
3 Years-10.48%
TTM-59.26%

Return on Capital

10 Years41.84%
5 Years33.67%
3 Years29.8%
Last Year11.27%

SIGA Recent Earnings

SIGA Technologies, Inc. (SIGA) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat Revenue 0/12 qtrs (0%)
Q2 2026Latest
May 7, 2026
Metric
Actual
Est
EPS
$0.05
—
Rev
$6M
—
Q2 2026
Mar 10, 2026
Metric
Actual
Est
EPS
$0.08
—
Rev
$4M
—
Q4 2025
Nov 6, 2025
Metric
Actual
Est
EPS
$0.09
—
Rev
$3M
—
Q3 2025
Aug 5, 2025
Metric
Actual
Est
EPS
$0.49
—
Rev
$81M
—
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 7, 2026
$0.05
$6M
Q2 2026Mar 10, 2026
$0.08
$4M
Q4 2025Nov 6, 2025
$0.09
$3M
Q3 2025Aug 5, 2025
$0.49
$81M
Based on last 12 quarters of dataView full earnings history →

SIGA Peer Comparison

SIGA Technologies, Inc. (SIGA) competitors in Vaccines and biodefense products — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
GILD logoGILDGilead Sciences, Inc.Direct Competitor153.66B123.7618.252.39%30.99%42.33%1.09
AVTX logoAVTXAvalo Therapeutics, Inc.Direct Competitor166.02M14.70-2.52-86.62%-1436.27%-97.55%0.03
AGEN logoAGENAgenus Inc.Product Competitor124.93M3.00-882.3510.37%52.16%
VRTX logoVRTXVertex Pharmaceuticals IncorporatedProduct Competitor114.88B451.6329.489.57%35.4%23.93%0.21
REGN logoREGNRegeneron Pharmaceuticals, Inc.Product Competitor63.37B609.9414.700.99%29.65%14.32%0.09
MNKD logoMNKDMannKind CorporationProduct Competitor1.22B3.9419722.23%-6.63%
BAX logoBAXBaxter International Inc.Supply Chain10.27B19.89-11.375.72%-9.7%-16.5%1.64
MCK logoMCKMcKesson CorporationSupply Chain90.23B750.6319.5612.36%1.18%

Compare SIGA vs Peers

SIGA Technologies, Inc. (SIGA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs GILD

Most directly comparable listed peer for SIGA.

Scale Benchmark

vs VRTX

Larger-name benchmark to compare SIGA against a more recognizable public peer.

Peer Set

Compare Top 5

vs GILD, AVTX, AGEN, VRTX

SIGA Income Statement

SIGA Technologies, Inc. (SIGA) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
12.27M477.05M26.74M124.96M133.67M110.78M139.92M138.72M94.6M93.78M
Revenue Growth %
-18.14%3788.3%-94.39%367.28%6.97%-17.13%26.31%-0.86%-31.8%-22.06%
Cost of Goods Sold
16.68M108.29M15.09M25.74M16.6M10.43M17.83M31.29M29.7M32.49M
COGS % of Revenue
135.95%22.7%56.41%20.6%12.42%9.42%12.74%22.56%31.4%-
Gross Profit
-4.41M▲ 0%
368.77M▲ 8460.7%
11.66M▼ 96.8%
99.22M▲ 751.3%
117.07M▲ 18.0%
100.34M▼ 14.3%
122.09M▲ 21.7%
107.43M▼ 12.0%
64.87M▼ 39.6%
61.29M▲ 0%
Gross Margin %
-35.95%77.3%43.59%79.4%87.58%90.58%87.26%77.44%68.57%65.35%
Gross Profit Growth %
6.61%8460.67%-96.84%751.25%17.99%-14.29%21.67%-12.01%-39.62%-
Operating Expenses
13.21M13.67M13.98M14.72M27.98M57.64M38.47M37.45M41.17M40.65M
OpEx % of Revenue
107.69%2.87%52.27%11.78%20.93%52.04%27.5%26.99%43.52%-
Selling, General & Admin
12.3M12.88M13.25M14.72M18.03M35.12M22.04M25.14M3.13M4.67T
SG&A % of Revenue
100.28%2.7%49.56%11.78%13.49%31.7%15.75%18.12%3.31%-
Research & Development
16.68M13.02M009.94M22.53M16.43M12.31M6.53M2.7T
R&D % of Revenue
135.95%2.73%--7.44%20.33%11.74%8.87%6.9%-
Other Operating Expenses
16.79K78.94M726.11K0000031.51M0
Operating Income
-18.85M▲ 0%
355.1M▲ 1983.9%
-2.32M▼ 100.7%
84.5M▲ 3738.9%
89.09M▲ 5.4%
42.7M▼ 52.1%
83.62M▲ 95.8%
69.98M▼ 16.3%
23.7M▼ 66.1%
20.64M▲ 0%
Operating Margin %
-153.63%74.44%-8.68%67.62%66.65%38.55%59.76%50.45%25.05%22%
Operating Income Growth %
39.23%1983.9%-100.65%3738.91%5.43%-52.07%95.83%-16.31%-66.13%-
EBITDA
-18.72M355.17M-1.8M85.03M89.62M43.22M84.16M70.52M24.26M21.07M
EBITDA Margin %
-152.56%74.45%-6.71%68.05%67.04%39.01%60.15%50.84%25.65%22.46%
EBITDA Growth %
39.31%1997.58%-100.51%4836.69%5.39%-51.77%94.73%-16.2%-65.6%-62.95%
D&A (Non-Cash Add-back)
132.19K69.63K527K529.81K522.37K517.64K538.29K538.42K562.61K430.73K
EBIT
-23.57M427.12M5.59M76.53M89.09M42.7M83.62M69.98M23.7M24.1M
Net Interest Income
-14.76M-15.48M-15.77M-3.02M00006.68M4.41M
Interest Income
000000006.68M4.41M
Interest Expense
14.76M15.48M15.77M3.02M000000
Other Income/Expense
-19.48M56.54M-7.86M-10.99M218.94K1.43M4.16M6.09M6.7M6.29M
Pretax Income
-38.33M▲ 0%
411.64M▲ 1174.0%
-10.18M▼ 102.5%
73.51M▲ 822.2%
89.31M▲ 21.5%
44.13M▼ 50.6%
87.78M▲ 98.9%
76.07M▼ 13.3%
30.4M▼ 60.0%
26.93M▲ 0%
Pretax Margin %
-312.41%86.29%-38.06%58.83%66.81%39.84%62.73%54.84%32.14%28.71%
Income Tax
-2.09M-10.17M-2.94M17.17M19.86M10.23M19.71M16.86M7.1M6.67M
Effective Tax Rate %
5.46%-2.47%28.86%23.35%22.24%23.18%22.45%22.16%23.36%24.78%
Net Income
-36.24M▲ 0%
421.81M▲ 1264.1%
-7.24M▼ 101.7%
56.34M▲ 878.1%
69.45M▲ 23.3%
33.9M▼ 51.2%
68.07M▲ 100.8%
59.21M▼ 13.0%
23.3M▼ 60.7%
20.26M▲ 0%
Net Margin %
-295.34%88.42%-27.08%45.09%51.96%30.61%48.65%42.69%24.63%21.61%
Net Income Growth %
8.72%1264.07%-101.72%878.08%23.27%-51.18%100.76%-13.01%-60.65%-58.25%
Net Income (Continuing)
-36.24M421.81M-7.24M56.34M69.45M33.9M68.07M59.21M23.3M20.25M
Discontinued Operations
0000000000
Minority Interest
0000000000
EPS (Diluted)
-0.46▲ 0%
5.10▲ 1208.7%
-0.09▼ 101.7%
0.71▲ 905.9%
0.91▲ 28.2%
0.46▼ 49.5%
0.95▲ 106.5%
0.83▼ 12.6%
0.33▼ 60.2%
0.28▲ 0%
EPS Growth %
33.33%1208.7%-101.73%905.9%28.17%-49.45%106.52%-12.63%-60.24%-59.26%
EPS (Basic)
-0.465.28-0.090.710.920.460.950.830.33-
Diluted Shares Outstanding
78.87M82.71M82.18M79.44M76.4M73.55M71.68M71.77M71.6M71.65M
Basic Shares Outstanding
78.77M79.92M81.03M79.26M75.32M72.93M71.36M71.25M71.6M71.65M
Dividend Payout Ratio
-----97.16%47.21%72.05%185.05%-

SIGA Balance Sheet

SIGA Technologies, Inc. (SIGA) balance sheet — assets, liabilities & shareholders' equity

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
37.36M121.29M180.04M143.61M208.75M185.79M238.99M231.04M212.86M211.53M
Cash & Short-Term Investments
19.86M100.65M65.25M117.89M103.14M98.79M150.15M155.4M154.97M145.56M
Cash Only
19.86M100.65M65.25M117.89M103.14M98.79M150.15M155.4M154.97M145.56M
Short-Term Investments
0000000000
Accounts Receivable
1.8M1.96M4.17M3.34M83.65M45.41M21.13M21.17M3.26M4.5M
Days Sales Outstanding
53.611.556.899.76228.42149.6155.1255.6912.5916.29
Inventory
2.98M2.91M9.65M20.27M19.51M39.27M64.22M49.56M49.05M56.49M
Days Inventory Outstanding
65.289.8233.55287.41428.941.37K1.31K578.18602.78531.35
Other Current Assets
10.7M11.45M95.74M002.32M3.5M4.91M5.57M4.97M
Total Non-Current Assets
107.31M82.15M18.52M6.22M5.97M9.25M15.36M13.29M6.61M7.86M
Property, Plant & Equipment
138.64K171.27K2.62M2.1M2.37M1.85M1.33M1.3M1.09M1.67M
Fixed Asset Turnover
88.50x2785.33x10.21x59.39x56.50x59.93x105.07x106.84x86.72x74.87x
Goodwill
898.33K898.33K898.33K898.33K898.33K898.33K898.33K898.33K898.33K898.33K
Intangible Assets
0000000000
Long-Term Investments
96.59M68.29M00000000
Other Non-Current Assets
7.24M1.06M856.77K676.92K286.58K252.55K2.08M240.68K192.89K203.36K
Total Assets
144.67M▲ 0%
203.44M▲ 40.6%
198.57M▼ 2.4%
149.83M▼ 24.5%
214.73M▲ 43.3%
195.04M▼ 9.2%
254.35M▲ 30.4%
244.34M▼ 3.9%
219.47M▼ 10.2%
219.39M▲ 0%
Asset Turnover
0.08x2.34x0.13x0.83x0.62x0.57x0.55x0.57x0.43x0.41x
Asset Growth %
-10.13%40.63%-2.4%-24.54%43.31%-9.17%30.41%-3.94%-10.18%19.32%
Total Current Liabilities
6.81M11.34M91.74M10.48M30.49M21.52M54.12M25.33M17.99M65.16M
Accounts Payable
1.33M1.69M3.05M1.28M2.03M3.36M1.46M1.34M824.52K6.31M
Days Payables Outstanding
29.085.6973.8918.1344.59117.3929.8215.6410.1337.51
Short-Term Debt
0080.04M000000538.23K
Deferred Revenue (Current)
1.26M4.16M2.3M3.28M3.76M10.55M20.79M10.33M10.24M29.36M
Other Current Liabilities
1.36M5.03M3.61M3.42M4.24M3.66M6.82M3.07M4M47.76M
Current Ratio
5.49x10.70x1.96x13.70x6.85x8.63x4.42x9.12x11.83x3.25x
Quick Ratio
5.05x10.44x1.86x11.77x6.21x6.81x3.23x7.16x9.10x2.38x
Cash Conversion Cycle
89.825.61216.54279.04612.771.41K1.34K618.24605.24510.13
Total Non-Current Liabilities
461M89.19M9.05M9.55M9.92M3.36M3.38M3.2M2.65M2.61M
Long-Term Debt
71.05M75.55M00000000
Capital Lease Obligations
000000000431.88K
Deferred Tax Liabilities
11.47M479.41K00000000
Other Non-Current Liabilities
12.31M13.64M9.05M9.55M9.92M3.36M3.38M3.2M2.65M2.51M
Total Liabilities
467.81M100.53M100.78M20.04M40.41M24.88M57.49M28.53M20.65M67.77M
Total Debt
71.05M75.55M80.46M449.94K466.83K528.17K564.01K546.82K595.17K638.23K
Net Debt
51.19M-25.11M15.22M-117.44M-102.67M-98.26M-149.58M-154.85M-154.37M-144.92M
Debt / Equity
-0.73x0.82x0.00x0.00x0.00x0.00x0.00x0.00x0.00x
Debt / EBITDA
-0.21x-0.01x0.01x0.01x0.01x0.01x0.02x0.03x
Net Debt / EBITDA
--0.07x--1.38x-1.15x-2.27x-1.78x-2.20x-6.36x-6.88x
Interest Coverage
-1.60x27.59x0.35x25.37x------
Total Equity
-323.14M▲ 0%
102.91M▲ 131.8%
97.78M▼ 5.0%
129.79M▲ 32.7%
174.31M▲ 34.3%
170.16M▼ 2.4%
196.86M▲ 15.7%
215.8M▲ 9.6%
198.82M▼ 7.9%
151.62M▲ 0%
Equity Growth %
-12.43%131.85%-4.99%32.73%34.3%-2.38%15.69%9.62%-7.87%7.29%
Book Value per Share
-4.101.241.191.632.282.312.753.012.782.12
Total Shareholders' Equity
-323.14M102.91M97.78M129.79M174.31M170.16M196.86M215.8M198.82M151.62M
Common Stock
7.9K8.08K8.13K7.72K7.35K7.27K7.11K7.14K7.16K7.17K
Retained Earnings
-537.38M-115.79M-123.03M-95.19M-51.76M-63.8M-38.94M-22.84M-43.07M-90.44M
Treasury Stock
0000000000
Accumulated OCI
-3.35M-3.24M00000000
Minority Interest
0000000000

SIGA Cash Flow Statement

SIGA Technologies, Inc. (SIGA) cash flow — operating, investing & free cash flow history

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
-8.16M68.87M-18.2M71.52M11.49M41.61M94.8M48.76M43.47M27.75M
Operating CF Margin %
-66.5%14.44%-68.07%57.23%8.6%37.56%67.75%35.15%45.95%-
Operating CF Growth %
92.94%944.19%-126.43%492.87%-83.93%262%127.82%-48.56%-10.85%574.09%
Net Income
-36.24M421.81M-7.24M56.34M69.45M33.9M68.07M59.21M23.28M20.26M
Depreciation & Amortization
132.19K69.63K527K529.81K522.37K517.64K538.29K538.42K562.61K577.25K
Stock-Based Compensation
1.1M2.27M2.11M1.35M1.27M1.78M2.05M3.64M3.68M3.53M
Deferred Taxes
-2.72M-9.3M-2.42M11.61M121.45K-3.83M-4.8M193.42K6.43M0
Other Non-Cash Items
21.23M-348.87M-593.99K9.39M501K-199.19K579.24K-10.13M1.26M13.31M
Working Capital Changes
8.34M2.89M-10.59M-7.7M-60.37M9.44M28.36M-4.69M8.26M-9.91M
Change in Receivables
1.35M-49.72K-2.21M827.73K-80.31M38.24M24.28M-35.18K17.9M2.68M
Change in Inventory
22.69M39-6.74M-8.01M136.37K-19.96M-25.52M15.34M-846.31K1.21M
Change in Payables
-1.85M1.62M936.84K-2.2M1.47M2.07M2M-5.74M-578.64K-3.71M
Cash from Investing
-100.12K78.24M-29.09K-15.5K-50.62K0-21.69K-42.45K-355.01K-330.12K
Capital Expenditures
-100.12K-102.26K-29.09K-15.5K-50.62K0-21.69K-42.45K-355.01K-330.12K
CapEx % of Revenue
0.82%0.02%0.11%0.01%0.04%-0.02%0.03%0.38%0.35%
Acquisitions
0000000000
Investments
----------
Other Investing
078.34M00000000
Cash from Financing
-585.57K-3.81M-1.18M-114.6M-26.2M-45.96M-43.42M-43.46M-43.55M-44.12M
Debt Issued (Net)
000-85.91M000000
Equity Issued (Net)
-591.07K00-28.5M-26.02M-13.01M-11.07M00-267.57K
Dividends Paid
00000-32.94M-32.14M-42.67M-43.12M-43.28M
Share Repurchases
-591.07K-4.07M0-28.5M-26.02M-13.01M-11.07M00-267.57K
Other Financing
5.5K-3.81M-1.18M-184.02K-173.92K-12.53K-214.79K-799.89K-433.76K-581K
Net Change in Cash
-8.84M▲ 0%
143.3M▲ 1720.3%
-19.41M▼ 113.5%
-43.1M▼ 122.0%
-14.75M▲ 65.8%
-4.35M▲ 70.5%
51.36M▲ 1281.1%
5.25M▼ 89.8%
-433.85K▼ 108.3%
-16.71M▲ 0%
Free Cash Flow
-8.26M▲ 0%
68.77M▲ 932.7%
-18.23M▼ 126.5%
71.5M▲ 492.2%
11.44M▼ 84.0%
41.61M▲ 263.6%
94.78M▲ 127.8%
48.72M▼ 48.6%
43.12M▼ 11.5%
27.42M▲ 0%
FCF Margin %
-67.31%14.42%-68.18%57.22%8.56%37.56%67.74%35.12%45.58%29.23%
FCF Growth %
92.86%932.71%-126.51%492.16%-84%263.61%127.77%-48.6%-11.5%-55.69%
FCF per Share
-0.100.83-0.220.900.150.571.320.680.600.38
FCF Conversion (FCF/Net Income)
0.23x0.16x2.51x1.27x0.17x1.23x1.39x0.82x1.87x1.35x
Interest Paid
10.29M000000000
Taxes Paid
325K251.96K03.72M1.06M31.37M3.5M30.36M8.2M0

SIGA Key Ratios

SIGA Technologies, Inc. (SIGA) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)
-409.86%-7.22%49.51%45.68%19.68%37.09%28.7%11.24%10.62%
Return on Invested Capital (ROIC)
-342.28%-1.83%101.12%159.1%44.62%105.25%96.99%33.73%55.77%
Gross Margin
-35.95%77.3%43.59%79.4%87.58%90.58%87.26%77.44%68.57%65.35%
Net Margin
-295.34%88.42%-27.08%45.09%51.96%30.61%48.65%42.69%24.63%21.61%
Debt / Equity
-0.73x0.82x0.00x0.00x0.00x0.00x0.00x0.00x0.00x
Interest Coverage
-1.60x27.59x0.35x25.37x------
FCF Conversion
0.23x0.16x2.51x1.27x0.17x1.23x1.39x0.82x1.87x1.35x
Revenue Growth
-18.14%3788.3%-94.39%367.28%6.97%-17.13%26.31%-0.86%-31.8%-22.06%
Related:SIGA Dividend History·SIGA Revenue History·SIGA Price History·SIGA P/E History·SIGA Financial Ratios·SIGA Institutional Holders

SIGA SEC Filings & Documents

SIGA Technologies, Inc. (SIGA) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 7, 2026·SEC

Material company update

Mar 26, 2026·SEC

Material company update

Mar 10, 2026·SEC

10-K Annual Reports

4
FY 2026

Mar 10, 2026·SEC

FY 2025

Mar 11, 2025·SEC

FY 2024

Mar 12, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 7, 2026·SEC

FY 2025

Nov 6, 2025·SEC

FY 2025

Aug 5, 2025·SEC

SIGA Frequently Asked Questions

SIGA Technologies, Inc. (SIGA) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

SIGA Technologies, Inc. (SIGA) reported $93.8M in revenue for fiscal year 2025. This represents a 93683% increase from $0.1M in 1996.

SIGA Technologies, Inc. (SIGA) saw revenue decline by 31.8% over the past year.

Yes, SIGA Technologies, Inc. (SIGA) is profitable, generating $20.3M in net income for fiscal year 2025 (24.6% net margin).

Dividend & Returns

Yes, SIGA Technologies, Inc. (SIGA) pays a dividend with a yield of 13.94%. This makes it attractive for income-focused investors.

SIGA Technologies, Inc. (SIGA) has a return on equity (ROE) of 11.2%. This is reasonable for most industries.

SIGA Technologies, Inc. (SIGA) generated $27.4M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in SIGA back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →

How much would $100/month in SIGA be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →